Alector to Participate in Upcoming Healthcare Conferences
Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the ...
Studies of Parkinson's disease have long overlooked Pacific populations—meta-analysis shows why that must change
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
Men's immune response to brain protein may explain their higher rates of Parkinson's disease
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
News Medical on MSN21h
FDA-approved technology offers personalized treatment for Parkinson’s symptoms
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
GB News on MSN16h
Motorists issued DVLA warning as 'extensive list' of medical conditions may lead to £1k driving licence fine
Drivers are being warned that they risk a £1,000 fine if they do not tell the DVLA about medical conditions that could lead ...